Kees Been
Supervisory Board
Probiodrug
Germany
Biography
Kees Been has over 20 years’ experience in the biotech/pharma industry as the current CEO of Lysosomal Therapeutics, the former President/CEO of EnVivo Pharmaceuticals, CEO of Bionaut Pharmaceuticals, Senior Vice President of Business Development at Biogen and Head of Biogen’s Oncology Business Unit. He has also held senior roles in Monsanto Life Sciences Company and Gemini Consulting. Mr Been holds an MBA degree from INSEAD in France and a Master’s degree from the University of Agriculture in Holland, majoring in Molecular Biology and Process Engineering.
Research Interest
Molecular Biology
